2933599092
Anti cancer drug raw materials (imatinib mesylate, azathioprine, pemetrexed disodium, calcium folinate, fluoromethanib mesylate, amitinib mesylate, Zebutinib, Orebutinib)
Not applicable to the value-added tax policy for anti-cancer drugsDeclaration Elements
0: Brand type
1: Export benefits situation
2: Ingredient content
3: Purpose:
4: Packaging specifications
5: Brand (Chinese or foreign name)
6: Model number
7: Signing Date
8:GTIN
9:CAS
10: Other
By each trade agreement
RCEP
Directory
CIQ
Anti cancer drug raw materials (imatinib mesylate, azathioprine, pemetrexed disodium, calcium folinate, fluoromethanib mesylate, amitinib mesylate, Zebutinib, Orebutinib) (not subject to value-added tax policies for anti-cancer drugs)
Disclaimer
The data on this page is sourced from publicly available information and is for reference only. It has no legal effect. Actual procedures should be based on the latest Import and Export Tariff Schedule and relevant laws and regulations issued by the General Administration of Customs.





